Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCC

Clinical trial NCT07177794 · RECRUITING

Trial details

NCT number: NCT07177794
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Esophageal Cancer Chemoradiotherapy

Start date: 2025-09-10
Primary completion: 2028-05-31
Enrollment: 242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.